Burning Rock Biotech (BNR) Long-Term Investments (2020 - 2024)
Historic Long-Term Investments for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2024 value amounting to $35000.0.
- Burning Rock Biotech's Long-Term Investments fell 3396.23% to $35000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $35000.0, marking a year-over-year decrease of 3396.23%. This contributed to the annual value of $47000.0 for FY2023, which is 5300.0% down from last year.
- Per Burning Rock Biotech's latest filing, its Long-Term Investments stood at $35000.0 for Q3 2024, which was down 3396.23% from $34000.0 recorded in Q2 2024.
- Burning Rock Biotech's 5-year Long-Term Investments high stood at $250000.0 for Q2 2020, and its period low was $34000.0 during Q1 2024.
- Over the past 5 years, Burning Rock Biotech's median Long-Term Investments value was $104500.0 (recorded in 2022), while the average stood at $121722.2.
- Per our database at Business Quant, Burning Rock Biotech's Long-Term Investments plummeted by 2200.0% in 2021 and then plummeted by 6091.95% in 2024.
- Quarter analysis of 5 years shows Burning Rock Biotech's Long-Term Investments stood at $217000.0 in 2020, then plummeted by 34.1% to $143000.0 in 2021, then crashed by 30.07% to $100000.0 in 2022, then tumbled by 53.0% to $47000.0 in 2023, then decreased by 25.53% to $35000.0 in 2024.
- Its Long-Term Investments was $35000.0 in Q3 2024, compared to $34000.0 in Q2 2024 and $34000.0 in Q1 2024.